Assessing the impact of non-pharmaceutical interventions against COVID-19 on 64 notifiable infectious diseases in Australia: A Bayesian Structural Time Series model
Shovanur Haque , Stephen B. Lambert , Kerrie Mengersen , Ian G. Barr , Liping Wang , Puntani Pongsumpun , Zhongjie Li , Weizhong Yang , Sotiris Vardoulakis , Hilary Bambrick , Wenbiao Hu
{"title":"Assessing the impact of non-pharmaceutical interventions against COVID-19 on 64 notifiable infectious diseases in Australia: A Bayesian Structural Time Series model","authors":"Shovanur Haque , Stephen B. Lambert , Kerrie Mengersen , Ian G. Barr , Liping Wang , Puntani Pongsumpun , Zhongjie Li , Weizhong Yang , Sotiris Vardoulakis , Hilary Bambrick , Wenbiao Hu","doi":"10.1016/j.jiph.2025.102679","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Several studies have examined the effect of non-pharmaceutical interventions (NPIs) on COVID-19 and other infectious diseases in Australia and globally. However, to our knowledge none have sufficiently explored their impact on other infectious diseases with robust time series model. In this study, we aimed to use Bayesian Structural Time Series model (BSTS) to systematically assess the impact of NPIs on 64 National Notifiable Infectious Diseases (NNIDs) by conducting a comprehensive and comparative analysis across eight disease categories within each Australian state and territory, as well as nationally.</div></div><div><h3>Methods</h3><div>Monthly data on 64 NNIDs from eight categories were obtained from the Australian National Notifiable Disease Surveillance System. The incidence rates for each infectious disease in 2020 were compared with the 2015–2019 average and then with the expected rates in 2020 using a BSTS model. The study investigated the causal effects of 2020 interventions and analysed the impact of government policy restrictions at the national level from January 2020 to December 2022.</div></div><div><h3>Results</h3><div>During the COVID-19 pandemic interventions in Australia, there was a 38 % (95 % Credible Interval [CI] [9 %, 54 %]) overall relative reduction in incidence reported across all disease categories compared to the 2015–2019 average. Significant reductions were observed in bloodborne diseases: 20 % (95 % CI [10 %, 29 %]), respiratory diseases: 79 % (95 % CI [52 %, 91 %]), and zoonoses: 8 % (95 % CI [1 %, 17 %]). Conversely, vector-borne diseases increased by 9 % over the same period. Reductions and intervention effects varied by state and territory, with higher policy stringency linked to fewer cases for some diseases.</div></div><div><h3>Conclusions</h3><div>COVID-19 NPIs also impacted the transmission of other infectious diseases, with varying effects across regions reflecting diverse outcomes in response strategies throughout Australia. The findings could inform public health strategies and provide scientific evidence to support the development of early warning systems for future disease outbreaks.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"18 3","pages":"Article 102679"},"PeriodicalIF":4.7000,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Public Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1876034125000280","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Several studies have examined the effect of non-pharmaceutical interventions (NPIs) on COVID-19 and other infectious diseases in Australia and globally. However, to our knowledge none have sufficiently explored their impact on other infectious diseases with robust time series model. In this study, we aimed to use Bayesian Structural Time Series model (BSTS) to systematically assess the impact of NPIs on 64 National Notifiable Infectious Diseases (NNIDs) by conducting a comprehensive and comparative analysis across eight disease categories within each Australian state and territory, as well as nationally.
Methods
Monthly data on 64 NNIDs from eight categories were obtained from the Australian National Notifiable Disease Surveillance System. The incidence rates for each infectious disease in 2020 were compared with the 2015–2019 average and then with the expected rates in 2020 using a BSTS model. The study investigated the causal effects of 2020 interventions and analysed the impact of government policy restrictions at the national level from January 2020 to December 2022.
Results
During the COVID-19 pandemic interventions in Australia, there was a 38 % (95 % Credible Interval [CI] [9 %, 54 %]) overall relative reduction in incidence reported across all disease categories compared to the 2015–2019 average. Significant reductions were observed in bloodborne diseases: 20 % (95 % CI [10 %, 29 %]), respiratory diseases: 79 % (95 % CI [52 %, 91 %]), and zoonoses: 8 % (95 % CI [1 %, 17 %]). Conversely, vector-borne diseases increased by 9 % over the same period. Reductions and intervention effects varied by state and territory, with higher policy stringency linked to fewer cases for some diseases.
Conclusions
COVID-19 NPIs also impacted the transmission of other infectious diseases, with varying effects across regions reflecting diverse outcomes in response strategies throughout Australia. The findings could inform public health strategies and provide scientific evidence to support the development of early warning systems for future disease outbreaks.
期刊介绍:
The Journal of Infection and Public Health, first official journal of the Saudi Arabian Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences and the Saudi Association for Public Health, aims to be the foremost scientific, peer-reviewed journal encompassing infection prevention and control, microbiology, infectious diseases, public health and the application of healthcare epidemiology to the evaluation of health outcomes. The point of view of the journal is that infection and public health are closely intertwined and that advances in one area will have positive consequences on the other.
The journal will be useful to all health professionals who are partners in the management of patients with communicable diseases, keeping them up to date. The journal is proud to have an international and diverse editorial board that will assist and facilitate the publication of articles that reflect a global view on infection control and public health, as well as emphasizing our focus on supporting the needs of public health practitioners.
It is our aim to improve healthcare by reducing risk of infection and related adverse outcomes by critical review, selection, and dissemination of new and relevant information in the field of infection control, public health and infectious diseases in all healthcare settings and the community.